Covered recipient · General Payments record
TAMARA COPELAND
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,838.73
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.44 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $291.96 | 16 |
| Novo Nordisk AS | $51.70 | 3 |
| Exact Sciences Corporation | $33.06 | 2 |
| Astellas Pharma US Inc | $27.53 | 1 |
| Ethicon Inc. | $23.87 | 1 |
| Acerta Pharma LLC | $18.85 | 1 |
| GlaxoSmithKline, LLC. | $16.68 | 1 |
| PFIZER INC. | $15.98 | 1 |
| Lilly USA, LLC | $15.07 | 1 |
| Amgen Inc. | $14.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.66 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502222 | CMS |
| ABBVIE INC. | $32.18 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502224 | CMS |
| ABBVIE INC. | $21.28 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502226 | CMS |
| ABBVIE INC. | $14.14 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502228 | CMS |
| ABBVIE INC. | $17.45 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502230 | CMS |
| ABBVIE INC. | $20.52 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502232 | CMS |
| ABBVIE INC. | $27.52 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502234 | CMS |
| ABBVIE INC. | $15.21 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502236 | CMS |
| ABBVIE INC. | $13.32 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502238 | CMS |
| ABBVIE INC. | $8.43 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502240 | CMS |
| ABBVIE INC. | $23.77 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502242 | CMS |
| ABBVIE INC. | $20.77 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502244 | CMS |
| ABBVIE INC. | $9.18 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502246 | CMS |
| ABBVIE INC. | $17.98 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502248 | CMS |
| ABBVIE INC. | $7.55 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502250 | CMS |
| ABBVIE INC. | $34.00 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103502252 | CMS |
| Amgen Inc. | $14.74 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117531554 | CMS |
| Astellas Pharma US Inc | $27.53 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139354073 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.85 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104696922 | CMS |
| Ethicon Inc. | $23.87 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077583278 | CMS |
| Exact Sciences Corporation | $15.15 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114621724 | CMS |
| Exact Sciences Corporation | $17.91 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114621728 | CMS |
| GlaxoSmithKline, LLC. | $16.68 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116453615 | CMS |
| Lilly USA, LLC | $15.07 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135432661 | CMS |
| Novo Nordisk Inc | $17.51 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096622010 | CMS |
| Novo Nordisk Inc | $15.47 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096575863 | CMS |
| Novo Nordisk Inc | $18.72 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097327359 | CMS |
| PFIZER INC. | $15.98 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131804445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.